Patents by Inventor Matthew Lynn Peterson

Matthew Lynn Peterson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Sertraline compositions
    Patent number: 7186863
    Abstract: An acid salt of sertraline, wherein the acid is citric acid, fumaric acid, malic acid, maleic acid, malonic acid, phosphoric acid, succinic acid, sulfuric acid, L-tartaric acid, HBr, acetic acid, benzoic acid, benzenesulfonic acid, ethanesulfonic acid, lactic acid, methanesulfonic acid or toluenesulfonic acid. Similarly, a solvate of sertraline HCl, wherein the solvent is methanol, ethanol, n-propanol, isopropanol, n-butanol, isobutanol, t-butanol, acetic acid, ethyl acetate, or propylene glycol.
    Type: Grant
    Filed: May 21, 2004
    Date of Patent: March 6, 2007
    Assignee: TransForm Pharmaceuticals, Inc.
    Inventors: Julius Remenar, Michael MacPhee, Matthew Lynn Peterson, Mark Tawa
  • CIS-itraconazole crystalline forms and related processes, pharmaceutical compositions and methods
    Patent number: 7078526
    Abstract: The invention provides novel soluble conazole crystalline forms (e.g. itraconazole, posaconazole and saperconazole) that include salts, co-crystals and related solvates useful as pharmaceuticals. The invention also provides pharmaceutical compositions comprising, and processes for making, these conazole crystalline forms. Methods of using such compositions for the treatment or prevention of systemic and local fungal, yeast, and dermatophyte infections are also provided.
    Type: Grant
    Filed: May 30, 2003
    Date of Patent: July 18, 2006
    Assignee: TransForm Pharmaceuticals, Inc.
    Inventors: Jules Remenar, Michael MacPhee, Matthew Lynn Peterson, Sherry Lynn Morissette, Orn Almarsson
  • Novel conazole crystalline forms and related processes, pharmaceutical compositions and methods
    Publication number: 20040019211
    Abstract: The invention provides novel soluble conazole crystalline forms (e.g. itraconazole, posaconazole and saperconazole) that include salts, co-crystals and related solvates useful as pharmaceuticals. The invention also provides pharmaceutical compositions comprising, and processes for making, these conazole crystalline forms. Methods of using such compositions for the treatment or prevention of systemic and local fungal, yeast, and dermatophyte infections are also provided.
    Type: Application
    Filed: May 30, 2003
    Publication date: January 29, 2004
    Applicant: Transform Pharmaceuticals, Inc.
    Inventors: Jules Remenar, Michael MacPhee, Matthew Lynn Peterson, Sherry Lynn Morissette, Orn Almarsson